{{Infobox gene}}
'''次黃嘌呤-鳥嘌呤磷酸核苷轉移酶'''（Hypoxanthine-guanine phosphoribosyltransferase，簡稱HGPRT）為人體內一個轉譯自''HPRT1''[[基因|基因]]的[[酵素|酵素]]<ref name="Entrez">{{cite web |url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=retrieve&dopt=default&list_uids=3251&rn=1 |title=Entrez Gene: hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome)}}</ref><ref name="pmid12175903">{{citejournal | vauthors = Finette BA, Kendall H, Vacek PM | title = Mutational spectral analysis at the HPRT locus in healthy children | journal = Mutation Research | volume = 505 | issue = 1-2 | pages = 27–41 | date = Aug 2002 | pmid = 12175903 | doi = 10.1016/S0027-5107(02)00119-7 }}</ref>

HGPRT為一種[[轉移酶|轉移酶]]，可以催化將[[次黃嘌呤|次黃嘌呤]]轉換為[[肌苷酸|肌苷酸]]（IMP），也可將[[鳥嘌呤|鳥嘌呤]]的反應轉為[[單磷酸鳥苷|單磷酸鳥苷]]。這兩個反應都是將[[磷酸核糖焦磷酸|PRPP]]的5-磷酸核苷轉移至嘌呤上。HGPRT在[[核苷酸再利用合成途徑|核苷酸再利用合成途徑]]中扮演重要角色。

== 功能 ==
{{enzyme|align=left
| Name = hypoxanthine phosphoribosyltransferase
| EC_number = 2.4.2.8
| CAS_number = 9016-12-0
| IUBMB_EC_number = 2/4/2/8
| GO_code = 0004422
| image = 
| width = 
| caption = 
}}
HGPRT催化下列反應：

{| class="wikitable" style="text-align: center;"
!基質!!產地!! 備註
|-
| [[次黃嘌呤|次黃嘌呤]] || [[肌苷酸|肌苷酸]] || —
|- 
| [[鳥嘌呤|鳥嘌呤]]  || [[單磷酸鳥苷|單磷酸鳥苷]] || 常稱HGPRT，僅有部分物種有此功能。
|- 
| [[黄嘌呤|黄嘌呤]] || {{tsl|en|xanthosine monophosphate|單磷酸黃核苷|}} || 特定HPRT
|}

HGPRTase functions primarily to salvage purines from degraded DNA to reintroduce into purine synthetic pathways. In this role, it catalyzes the reaction between [[鳥嘌呤|guanine]] and [[磷酸核糖焦磷酸|phosphoribosyl pyrophosphate]] (PRPP) to form [[單磷酸鳥苷|GMP]], or between [[次黄嘌呤|hypoxanthine]] and [[磷酸核糖焦磷酸|phosphoribosyl pyrophosphate]] (PRPP) to form [[肌苷酸|inosine monophosphate]].
{{clear left}}

== Substrates and inhibitors ==

Comparative homology modelling of this enzyme in ''{{tsl|en|L. donovani||L. donovani}}'' suggest that among all of the computationally screened compounds, {{tsl|en|pentamidine||pentamidine}}, 1,3-dinitro[[金刚烷|adamantane]], [[阿昔洛韦|acyclovir]] and analogs of acyclovir had higher binding affinities than the real substrate (guanosine monophosphate).<ref name="pmid22327112">{{citejournal | vauthors = Ansari MY, Dikhit MR, Sahoo GC, Das P | title = Comparative modeling of HGPRT enzyme of L. donovani and binding affinities of different analogs of GMP | journal = International Journal of Biological Macromolecules | volume = 50 | issue = 3 | pages = 637–49 | date = Apr 2012 | pmid = 22327112 | doi = 10.1016/j.ijbiomac.2012.01.010 }}</ref>

== 疾病中的角色 ==
此基因的突變往往導致[[高尿酸血症|高尿酸血症]]：
<!-- Mutations in the gene lead to [[高尿酸血症|hyperuricemia]]:-->
* 一些男性帶有部分程度的HGPRT缺陷（約低於正常活動量20%）並因此導致血液中高濃度的[[尿酸|尿酸]]。隨之而來的是[[痛風|痛風]]以及[[腎結石|腎結石]]。這症狀稱為{{tsl|en|Kelley-Seegmiller syndrome}}。<!--Some men have partial (up to 20% less activity of the enzyme) HGPRT deficiency that causes high levels of [[尿酸|uric acid]] in the blood, which leads to the development of gouty arthritis and the formation of uric acid stones in the urinary tract. This condition has been named the {{tsl|en|Kelley-Seegmiller syndrome||Kelley-Seegmiller syndrome}}.--><ref name="pmid9651092">{{citejournal | vauthors = Khattak FH, Morris IM, Harris K | title = Kelley-Seegmiller syndrome: a case report and review of the literature | journal = British Journal of Rheumatology | volume = 37 | issue = 5 | pages = 580–1 | date = May 1998 | pmid = 9651092 | doi = 10.1093/rheumatology/37.5.580c }}</ref>
* {{tsl|en|Lesch-Nyhan syndrome|Lesch-Nyhan 症候群}}起源由HPRT1突變導致的HGPRT缺陷。<!--{{tsl|en|Lesch-Nyhan syndrome||Lesch-Nyhan syndrome}} is due to deficiency of HGPRT caused by HPRT1 mutation --><ref name="pmid18779430">{{citejournal | vauthors = Hladnik U, Nyhan WL, Bertelli M | title = Variable expression of HPRT deficiency in 5 members of a family with the same mutation | journal = Archives of Neurology | volume = 65 | issue = 9 | pages = 1240–3 | date = Sep 2008 | pmid = 18779430 | doi = 10.1001/archneur.65.9.1240 }}</ref>
* 某些基因突變可能導致[[痛風|痛風]]。發病的風險與hypoxanthine-guanine phosphoribosyltransferase的缺陷程度成正比。
<!--Some mutations have been linked to [[痛风|gout]], the risk of which is increased in hypoxanthine-guanine phosphoribosyltransferase deficiency.-->
[[File:PRTFDC1-Is-a-Genetic-Modifier-of-HPRT-Deficiency-in-the-Mouse-pone.0022381.s008.ogv|thumbtime=3]]
* HPRT expression on the mRNA and protein level is induced by hypoxia inducible factor 1 ({{tsl|en|HIF1A||HIF1A}}).  HIF-1 is a [[转录因子|transcription factor]] that directs an array of cellular responses that are used for adaptation during oxygen deprivation.  This finding implies that HPRT is a critical pathway that helps preserve the cell's [[嘌呤|purine]] nucleotide resources under hypoxic conditions as found in pathology such as [[冠狀動脈疾病|myocardial ischemia]].<ref name="pmid25681585">{{citejournal | vauthors = Wu J, Bond C, Chen P, Chen M, Li Y, Shohet RV, Wright G | title = HIF-1α in the heart: Remodeling nucleotide metabolism | journal = Journal of Molecular and Cellular Cardiology | date = Feb 2015 | pmid = 25681585 | doi = 10.1016/j.yjmcc.2015.01.014| volume=82 | pages=194–200}}</ref>

The [[in_silico|in silico]] and [[In_vitro|in-vitro]] correlation of these compounds were test in [[利什曼原蟲|Leishmania]] HGPRT and validates the result.<ref name="pmid26616453">{{cite journal | vauthors = Ansari MY, Equbal A, Dikhit MR, Mansuri R, Rana S, Ali V, Sahoo GC, Das P | title = Establishment of Correlation between In-Silico &In-Vitro Test Analysis against [[利什曼原蟲|Leishmania]] HGPRT to inhibitors | journal = International Journal of Biological Macromolecules | date = Nov 2015  | pmid = 26616453 | doi = 10.1016/j.ijbiomac.2015.11.051 | volume=83 | pages=78–96}}</ref>

== Hybridomas ==

{{tsl|en|Hybridoma||Hybridoma}}s are immortal (immune to {{tsl|en|cellular senescence||cellular senescence}}), HGPRT<sup>+</sup> cells that result from fusion of mortal, HGPRT<sup>+</sup> [[浆细胞|plasma cells]] and immortal, HGPRT<sup>−</sup> [[多發性骨髓瘤|myeloma]] cells. They are created to produce [[单克隆抗体|monoclonal antibodies]] in biotechnology. {{tsl|en|HAT medium||HAT medium}} inhibits [[从头合成|de novo synthesis]] of nucleic acids, killing myeloma cells that cannot switch over to the [[补救途径|salvage pathway]], due to lack of HRPT1. The plasma cells in the culture eventually die from senesence, leaving pure hybridoma cells.

== 參見 ==

== 參考文獻 ==
{{reflist|33em}}

== 延伸閱讀 ==
{{refbegin|33em}}
* {{citejournal | vauthors = Sculley DG, Dawson PA, Emmerson BT, Gordon RB | title = A review of the molecular basis of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency | journal = Human Genetics | volume = 90 | issue = 3 | pages = 195–207 | date = Nov 1992 | pmid = 1487231 | doi = 10.1007/bf00220062 }}
* {{citejournal | vauthors = Ansari MY, Dikhit MR, Sahoo GC, Das P | title = Comparative modeling of HGPRT enzyme of L. donovani and binding affinities of different analogs of GMP | journal = International Journal of Biological Macromolecules | volume = 50 | issue = 3 | pages = 637–49 | date = Apr 2012 | pmid = 22327112 | doi = 10.1016/j.ijbiomac.2012.01.010 }}
* {{citejournal | vauthors = Davidson BL, Tarlé SA, Van Antwerp M, Gibbs DA, Watts RW, Kelley WN, Palella TD | title = Identification of 17 independent mutations responsible for human hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency | journal = American Journal of Human Genetics | volume = 48 | issue = 5 | pages = 951–8 | date = May 1991 | pmid = 2018042 | pmc = 1683055 }}
* {{citejournal | vauthors = Stout JT, Caskey CT | title = HPRT: gene structure, expression, and mutation | journal = Annual Review of Genetics | volume = 19 | pages = 127–48 | date = 1986 | pmid = 3909940 | doi = 10.1146/annurev.ge.19.120185.001015 }}
* {{citejournal | vauthors = Sege-Peterson K, Chambers J, Page T, Jones OW, Nyhan WL | title = Characterization of mutations in phenotypic variants of hypoxanthine phosphoribosyltransferase deficiency | journal = Human Molecular Genetics | volume = 1 | issue = 6 | pages = 427–32 | date = Sep 1992 | pmid = 1301916 | doi = 10.1093/hmg/1.6.427 }}
* {{citejournal | vauthors = Lightfoot T, Joshi R, Nuki G, Snyder FF | title = The point mutation of hypoxanthine-guanine phosphoribosyltransferase (HPRTEdinburgh) and detection by allele-specific polymerase chain reaction | journal = Human Genetics | volume = 88 | issue = 6 | pages = 695–6 | date = Mar 1992 | pmid = 1551676 | doi = 10.1007/BF02265300 }}
* {{citejournal | vauthors = Yamada Y, Goto H, Ogasawara N | title = Identification of two independent Japanese mutant HPRT genes using the PCR technique | journal = Advances in Experimental Medicine and Biology | volume = 309B | pages = 121–4 | date = 1992 | pmid = 1840476 | doi = 10.1007/978-1-4615-7703-4_27 | isbn = 978-1-4615-7705-8 | series = Advances in Experimental Medicine and Biology }}
* {{citejournal | vauthors = Sculley DG, Dawson PA, Beacham IR, Emmerson BT, Gordon RB | title = Hypoxanthine-guanine phosphoribosyltransferase deficiency: analysis of HPRT mutations by direct sequencing and allele-specific amplification | journal = Human Genetics | volume = 87 | issue = 6 | pages = 688–92 | date = Oct 1991 | pmid = 1937471 | doi = 10.1007/BF00201727 }}
* {{citejournal | vauthors = Tarlé SA, Davidson BL, Wu VC, Zidar FJ, Seegmiller JE, Kelley WN, Palella TD | title = Determination of the mutations responsible for the Lesch-Nyhan syndrome in 17 subjects | journal = Genomics | volume = 10 | issue = 2 | pages = 499–501 | date = Jun 1991 | pmid = 2071157 | doi = 10.1016/0888-7543(91)90341-B }}
* {{citejournal | vauthors = Gordon RB, Sculley DG, Dawson PA, Beacham IR, Emmerson BT | title = Identification of a single nucleotide substitution in the coding sequence of in vitro amplified cDNA from a patient with partial HPRT deficiency (HPRTBRISBANE) | journal = Journal of Inherited Metabolic Disease | volume = 13 | issue = 5 | pages = 692–700 | date = 1991 | pmid = 2246854 | doi = 10.1007/BF01799570 }}
* {{citejournal | vauthors = Edwards A, Voss H, Rice P, Civitello A, Stegemann J, Schwager C, Zimmermann J, Erfle H, Caskey CT, Ansorge W | title = Automated DNA sequencing of the human HPRT locus | journal = Genomics | volume = 6 | issue = 4 | pages = 593–608 | date = Apr 1990 | pmid = 2341149 | doi = 10.1016/0888-7543(90)90493-E }}
* {{citejournal | vauthors = Gibbs RA, Nguyen PN, Edwards A, Civitello AB, Caskey CT | title = Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families | journal = Genomics | volume = 7 | issue = 2 | pages = 235–44 | date = Jun 1990 | pmid = 2347587 | doi = 10.1016/0888-7543(90)90545-6 }}
* {{citejournal | vauthors = Skopek TR, Recio L, Simpson D, Dallaire L, Melancon SB, Ogier H, O'Neill JP, Falta MT, Nicklas JA, Albertini RJ | title = Molecular analyses of a Lesch-Nyhan syndrome mutation (hprtMontreal) by use of T-lymphocyte cultures | journal = Human Genetics | volume = 85 | issue = 1 | pages = 111–6 | date = Jun 1990 | pmid = 2358296 | doi = 10.1007/BF00276334 }}
* {{citejournal | vauthors = Davidson BL, Tarlé SA, Palella TD, Kelley WN | title = Molecular basis of hypoxanthine-guanine phosphoribosyltransferase deficiency in ten subjects determined by direct sequencing of amplified transcripts | journal = The Journal of Clinical Investigation | volume = 84 | issue = 1 | pages = 342–6 | date = Jul 1989 | pmid = 2738157 | pmc = 303988 | doi = 10.1172/JCI114160 }}
* {{citejournal | vauthors = Ogasawara N, Stout JT, Goto H, Sonta S, Matsumoto A, Caskey CT | title = Molecular analysis of a female Lesch-Nyhan patient | journal = The Journal of Clinical Investigation | volume = 84 | issue = 3 | pages = 1024–7 | date = Sep 1989 | pmid = 2760209 | pmc = 329751 | doi = 10.1172/JCI114224 }}
* {{citejournal | vauthors = Yang TP, Stout JT, Konecki DS, Patel PI, Alford RL, Caskey CT | title = Spontaneous reversion of novel Lesch-Nyhan mutation by HPRT gene rearrangement | journal = Somatic Cell and Molecular Genetics | volume = 14 | issue = 3 | pages = 293–303 | date = May 1988 | pmid = 2835825 | doi = 10.1007/BF01534590 }}
* {{citejournal | vauthors = Fujimori S, Hidaka Y, Davidson BL, Palella TD, Kelley WN | title = Identification of a single nucleotide change in a mutant gene for hypoxanthine-guanine phosphoribosyltransferase (HPRT Ann Arbor) | journal = Human Genetics | volume = 79 | issue = 1 | pages = 39–43 | date = May 1988 | pmid = 2896620 | doi = 10.1007/BF00291707 }}
* {{citejournal | vauthors = Davidson BL, Pashmforoush M, Kelley WN, Palella TD | title = Human hypoxanthine-guanine phosphoribosyltransferase deficiency. The molecular defect in a patient with gout (HPRTAshville) | journal = The Journal of Biological Chemistry | volume = 264 | issue = 1 | pages = 520–5 | date = Jan 1989 | pmid = 2909537 }}
* {{citejournal | vauthors = Fujimori S, Davidson BL, Kelley WN, Palella TD | title = Identification of a single nucleotide change in the hypoxanthine-guanine phosphoribosyltransferase gene (HPRTYale) responsible for Lesch-Nyhan syndrome | journal = The Journal of Clinical Investigation | volume = 83 | issue = 1 | pages = 11–3 | date = Jan 1989 | pmid = 2910902 | pmc = 303636 | doi = 10.1172/JCI113846 }}
{{refend}}

== 外部連結 ==
* {{MeshName|Hypoxanthine+phosphoribosyltransferase}}
* [http://www.genome.jp/kegg/pathway/map/map00230.html Purine metabolism at genome.jp]
* [http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=lns  GeneReviews/NCBI/NIH/UW entry on Lesch-Nyhan Syndrome]

{{PDB Gallery|geneid=3251}}
{{Glycosyltransferases}}
{{Nucleotide metabolism}}

{{tsl|en|Category:EC 2.4.2||Category:EC 2.4.2}}